β-Blockers for Treatment of Heart Failure | AJMC
β-Blockers for Treatment of Heart Failure | AJMC
1 week ago
ajmc.com
Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Practices: Balazs Halmos, MD
Subcutaneous Amivantamab for NSCLC Could Benefit Patients, Practi…
1 week ago
ajmc.com
Innovations and Challenges in Screening for Alzheimer Disease: Ken Cohen, MD, FACP | AJMC
Innovations and Challenges in Screening for Alzheimer Disease: Ke…
2 weeks ago
ajmc.com
Linvoseltamab Demonstrates High Efficacy, Low Toxicity: Paula Rodríguez-Otero, MD, PhD | AJMC
Linvoseltamab Demonstrates High Efficacy, Low Toxicity: Paula Rodrígu…
2 weeks ago
ajmc.com
Roflumilast Delivers Speedy Improvement, Significant Itch Reduction in Younger Pediatric Patients: Lawrence F. Eichenfield, MD | AJMC
Roflumilast Delivers Speedy Improvement, Significant Itch Reduct…
1 week ago
ajmc.com
SGLT2 Inhibitors May Not Protect Against Cardiotoxicity From Cancer Treatment: Rakendu Rajendran, MBBS | AJMC
SGLT2 Inhibitors May Not Protect Against Cardiotoxicity From Cancer …
1 week ago
ajmc.com
Masks, Special Makeup Could Pose Issues for Eye Health Near Halloween: Douglas Lazzaro, MD | AJMC
Masks, Special Makeup Could Pose Issues for Eye Health Near Hallowee…
1 week ago
ajmc.com
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma | AJMC
Jan 4, 2021
ajmc.com
Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Dai…
Apr 1, 1999
ajmc.com
Dr David M. O'Malley on Identifying Which Patients Will Respond to PAR…
Mar 24, 2019
ajmc.com
Dr Swaminathan P. Iyer on Efficacy, Safety of CD70-Targeted CAR T-Cell …
Jun 11, 2022
ajmc.com
Dr Mrinal Gounder: Nirogacestat Approval Provides First-in-Class Opti…
Dec 8, 2023
ajmc.com
Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Dis…
Oct 25, 2020
ajmc.com
An Overview of B-Cell Malignancies | AJMC
Jan 21, 2020
ajmc.com
How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Outco…
Jul 28, 2023
ajmc.com
Dr Neil Gross: Cemiplimab Has Great Potential in cSCC | AJMC
Dec 5, 2022
ajmc.com
Infographic: A Brief History of ACA Repeal and Replace Efforts | AJMC
Jul 27, 2017
ajmc.com
Dr Jonathan Silverberg: Trial Washout Periods Are Methodologically Neces…
Apr 23, 2021
ajmc.com
Explaining Molecular Residual Disease | AJMC
Dec 22, 2021
ajmc.com
Dr Martin Makary Outlines Advantages, Disadvantages of Grou…
Jun 2, 2019
ajmc.com
Using Lenalidomide and Pomalidomide in RRMM Managemen…
Jun 21, 2022
ajmc.com
FDA Approves Fifth Neulasta Biosimilar | AJMC
Jun 2, 2022
ajmc.com
Dr Patrick Burnett Explains Mechanism of Action for Roflumilast …
Aug 25, 2022
ajmc.com
Dr David Rosmarin on Tailored Biologic Treatments, New Vitiligo Re…
Mar 27, 2022
ajmc.com
Dr Ajai Chari Explains MGUS and How to Discuss It With Patients | AJMC
Aug 31, 2019
ajmc.com
New CAR T Trial in MM Aims for Triple Receptor Targeting | AJMC
Aug 24, 2024
ajmc.com
Social Determinants of Health (SDoH) Impacting Treatment and Manageme…
Dec 7, 2022
ajmc.com
Dr Laurie Slovarp Outlines the Benefits of Behavioral Cough Suppression Th…
Jun 12, 2021
ajmc.com
Implications of Value-Based Care, Fee-for-Service Reimbursement Mo…
Mar 21, 2021
ajmc.com
Dabrafenib Plus Trametinib Approved as First Tumor-Agnostic Therapy for …
Jun 22, 2022
ajmc.com
See more videos
Static thumbnail place holder